# A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）

> **NCT06741098** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Nuwacell Biotechnologies Co., Ltd.** · enrollment: 162 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** NCR100
- **OTHER:** 0.9% Normal saline

## Key facts

- **NCT ID:** NCT06741098
- **Lead sponsor:** Nuwacell Biotechnologies Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-20
- **Primary completion:** 2026-11-30
- **Final completion:** 2028-11-15
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741098, "A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06741098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*